Malmstedt reported the role of the receptor for advanced glycation end products (RAGE), showing that higher circulating levels of an endogenous ligand for RAGE, the pro-inflammatory protein S100A12, was associated with increased risk for amputation or death and with earlier development of PAD [35]. Here, PROS1 is linked to peripheral arterial disease.